| Warfarin Sodium Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Warfarin Sodium 4 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 10 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 1 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 2 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 3 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 5 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 6 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 2.5 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 7.5 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium - | powder | compounding | 100.0 gram(s) | OTC |
Posted by cp9800 8 days ago
I suffered a DVT in 2006 followed by a venous cranial clot in March 2008. I have been on Coumadin since March. My experience ...
Posted by juststeph about 1 month ago
I am not sure what to think now. I too have a Protein C deficiency and developed one clot per lung in Dec 2006. I lost abou...
Posted by maggie14 about 1 month ago
24 yr female diagnosed with PE and DVT. I have been on Warfarin since may of 08 and it has turned my world upside down. Weigh...
FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium ... - Earthtimes
Patients on warfarin (such as Coumadin(R)) may need to be monitored more closely by their doctor. To learn more, talk to your doctor and see the full ...
Fri Feb 29 17:59:23 -0500 2008
China blacklists 141 seriously polluting products - Xinhua
The list included products closely linked to people's daily life, such as warfarin, mirex, DDT and nickel-cadmium cell, said Pan Yue, State Environmental ...
Tue Feb 26 07:20:03 -0500 2008
China blacklists 141 seriously polluting products - People's Daily Online
The list included products closely linked to people's daily life, such as warfarin, mirex, DDT and nickel-cadmium cell, said Pan Yue, State Environmental ...
Tue Feb 26 08:16:05 -0500 2008
warfarin sodium - The sodium salt form of warfarin, a coumarin and a vitamin K antagonist, with anticoagulant activity. Warfarin sodium inhibits both vitamin K and vitamin K epoxide reductases, thereby interfering with the cyclic interconversion of vitamin K epoxide to its reduced form, vitamin KH2. Vitamin KH2 is a cofactor for the carboxylation of glutamate residues on the N-terminal regions of vitamin K-dependent proteins. As a result, maturation of vitamin K-dependent coagulation factors II, VII, IX, and X and anticoagulant proteins C and S is inhibited. Without these coagulation factors, thrombogenesis and blood clot formation are prevented.